Description
Bacteriostatic water (bac water) is sold separately.
Wolverine Stack combines BPC-157 and the TB-500 research fragment as a lyophilised powder blend in one vial. The two peptides are presented as distinct research compounds with complementary laboratory study areas.
Potential Benefits — Research Is Ongoing
Potential benefits draw mainly on preclinical research into BPC-157 and thymosin-related peptides. Human benefits of this exact blend remain unconfirmed; TB-500 and full-length thymosin beta-4 are not interchangeable evidence.
- Tendon recovery: May support repair processes in damaged tendon tissue.
- Connective-tissue rebuilding: May encourage collagen organisation and tissue remodelling.
- Soft-tissue recovery: May support repair signalling in injured muscle and related tissue.
- Repair-cell activity: May encourage the movement and activity of cells involved in recovery.
- Local blood-supply support: May influence blood-vessel formation involved in tissue repair.
Research sources: BPC-157 and TB-500 rat tendon study; Tendon repair-cell study; Muscle-healing animal study.
Research Overview
Wolverine Stack pairs BPC-157 with the TB-500 fragment identified below. Its scientific context comes mainly from experiments on individual peptides in cell, tissue and animal models. Combining those compounds does not turn separate findings into clinical evidence for the blend.
Mechanism / Pathway
The BPC-157 study associated fibroblast migration with FAK–paxillin signalling, a pathway involved in how cells attach and move. Thymosin-related research examines actin-associated processes and tissue repair. Full-length thymosin beta-4, an unmodified domain peptide and an acetylated fragment must remain distinct when interpreting results.
Important Research Information
The cited evidence does not demonstrate healing of human tendon or ligament injuries, improved athletic recovery or human-use safety of this vial. No synergy or superiority claim is made for the blend. Results vary with peptide identity, concentration, delivery and model; the listed total content is a product specification, not a clinical outcome.
Published Research
- [1] Chang et al. (2011): BPC-157 in tendon explants and fibroblast cultures.
- [2] Philp et al. (2003): Thymosin beta-4 and an actin-binding domain peptide in animal wound models.
Scientific Profile
Research Areas
The constituent peptides are studied separately and in combination across repair-related cellular models.
- Cell migration and cytoskeletal organisation
- Angiogenesis and vascular-response models
- Tendon, ligament and connective-tissue research
- Gastrointestinal barrier and mucosal models
- Inflammatory-response and recovery pathways
Wolverine Stack 10 mg Vial
BPC-157 + TB-500, supplied as lyophilised powder in a B&A Premium vial with a holographic product label.
About this vial presentation
Wolverine Stack 10 mg Vial is supplied as one vial in the B&A Premium range. The labelled amount of 10 mg total refers to the total contents of the vial, rather than a dose or liquid volume. Use the actual batch label to confirm identity, total dry content, storage and expiry information. This vial is supplied as lyophilised powder, not as a liquid or ready-made solution.
Browse the vial collection to compare product names, quantities and formats. Bacteriostatic water is sold separately; this does not establish that it is compatible with this formulation. For documentation relating to Wolverine Stack 10 mg Vial, contact B&A Premium with the batch reference.
Product details
- Contents: BPC-157 + TB-500
- Labelled amount per vial: 10 mg total
- Presentation: lyophilised powder in a vial
- Pack: 1 vial
Storage
Keep refrigerated at 2–8°C and protected from light. Follow the batch label for expiry and handling instructions.
Important research information
For research use only. The labelled amount is the total content per vial, not a dose. Product artwork is illustrative; consult the supplied label for batch-specific details.
Looking for another presentation? View the Wolverine Stack 10 mg prefilled pen. Compare each listing’s format and labelled contents; vial powder and prefilled pens are separate presentations.
Warnings, Contraindications & Safety Information
Research use only. This is an evidence-limited safety summary, not a package insert, complete prescribing information or permission for self-administration. References to licensed medicines describe those specific products; they do not establish B&A product approval, equivalence or safety.
Contraindications & Who Should Avoid Exposure
A clinically validated contraindication list for this exact research presentation has not been established. That absence is not evidence of safety. Do not expose a person with a known allergy to a labelled ingredient or excipient.
Warnings & Precautions
This research presentation has not been established as safe for human administration. Do not use during pregnancy or breastfeeding, or in children. A serious medical condition, including cancer or significant liver or kidney disease, requires professional assessment; this page cannot establish suitability.
Blend-specific uncertainty: Combining ingredients may introduce additional or additive risks. Studies of separate compounds do not establish this blend’s interactions, compatibility, stability or safe use.
Possible Adverse Reactions
Reliable frequencies and a complete human adverse-reaction profile for this exact product are unavailable. Allergy, local irritation and contamination-related harm remain possible; absence of reports does not establish absence of risk.
Drug & Supplement Interactions
Drug and supplement interactions have not been adequately characterised for this presentation. Do not assume that combining it with prescription medicines, hormones or other research compounds is safe. Give a clinician the full ingredient list if exposure has occurred.
When to Seek Urgent Help
Seek emergency care for difficulty breathing, swelling of the face or throat, collapse, severe persistent abdominal pain, or repeated vomiting with inability to keep fluids down. Stop further exposure and show the clinician the product label and ingredient list.
Handling & Storage Cautions
Follow the actual product label and batch-specific expiry information. Do not use damaged, contaminated or unexpectedly changed material. Powder appearance, refrigeration or addition of bacteriostatic water does not prove sterility, compatibility or a safe shelf life. Do not share needles, pens or opened material between people.
Safety references: FDA research-peptide and compounding safety context. Information reviewed 20 October 2026.
Reviews
There are no reviews yet.